Mechanisms of angiogenesis in vascular disorders: Potential therapeutic targets

Drugs of the Future

Volumn 23, Issue 1, 1998, Pages 51-60

  Mousa, Shaker A ^a  

^a DUPONT COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AE 941; ALPHA INTERFERON; ANGIOGENIC FACTOR; ANGIOSTATIN; ARGINYLGLYCYLASPARTIC ACID; BASIC FIBROBLAST GROWTH FACTOR; BETA INTERFERON; COLLAGENASE; ENDOSTATIN; FIBRINOGEN; GELATINASE A; GELATINASE B; INTEGRIN; INTERLEUKIN 6; INTERLEUKIN 8; LAMININ; LAMININ RECEPTOR; MARIMASTAT; MATRIGEL; MATRIX METALLOPROTEINASE INHIBITOR; OSTEOPONTIN; PROTEIN TYROSINE KINASE; RIBOZYME; SOMATOMEDIN C; STROMELYSIN; THROMBOCYTE FACTOR 4; THROMBOSPONDIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN; VITRONECTIN;

ANGIOGENESIS; ARTICLE; CELL ADHESION; DRUG MECHANISM; ENZYME INHIBITION; HUMAN; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; SIGNAL TRANSDUCTION; WOUND HEALING;

EID: 0031911347     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.1998.023.01.858340     Document Type: Article

References (16)

1. Folkman, J., Cole, P., Zimmerman, S. Tumor behavior in isolated perfused organs: In vitro growth and metastasis of biopsy material in rabbit thyroid and canine intestinal segments. Ann Surg 1996, 164: 491.
2. Klagsbrum, M., D'Amore, P.A. Regulators of angiogenesis. Annu Rev Physiol 1991, 53: 217.
3. Polverini, P.J. Inhibitors of neovascularization: Critical mediators in the coordinate regulation of angiogenesis. In: Angiogenesis - Molecular Biology, Clinical Aspects. Maragondakis et al. (Eds.). Plenum Press: New York 1994, 263: 29.
4. Rouoslathi, E., Piershbacher, M.D. Arg-Gly-Asp: A versatile cell recognition signal. Cell 1986, 44: 517.
5. Catravas, J.D., Gills, C.N., Ryan, V.S. (Eds.). Vascular Endothelium: Receptors and Transduction Mechanisms. Plenum Press: New York 1989.
6. Friedlander, M., Brooks, P.C., Shaffer, R.W., Kincaid, C.M., Varner, J.A., Cheresh, D.A. Definition of two angiogenic pathways by distinct αv integrins. Science 1995, 270: 1500.
7. Lelkes, P.I. New aspects of endothelial cell biology. J Cell Biochem 1991, 45: 242.
8. Good, D.J., Polverini, P.J., Rastinejad, F. et al. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci USA 1990, 87: 6624.
9. Folkman, J. Anti-angiogenesis: A new concept of therapy of solid tumors. Ann Surg 1972, 175: 409.
10. O'Reilly, M.S., Holmgren, L., Shing, Y. et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994, 79: 316.
11. Holmgren, L., O'Reilly, M.S., Folkman, J. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1995, 1: 149.
12. O'Reilly, M.S., Holmgren, L., Chen, C.C., Folkman, J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med 1996, 2: 689.
13. Gately, S., Twardowski, P., Stack, M.S. et al. Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin. Cancer Res 1996, 56: 4887.
14. O'Reilly, M.S., Boehm, T., Shing, Y. et al. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 1997, 88: 277.
15. D'Amato, R. 3rd Annual IBC Angiogenesis Conference, 1997.
16. Hellerqvist, C.G., Thurman, G.B., Page, D.L. et al. Antitumor effects of GBS toxin: A polysaccharide exotoxin from group B -hemolytic streptococcus. J Cancer Res Clin Oncol 1993, 120: 63.